Vimarsana
Biggest News Aggregation in the World

Vanda Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vanda Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vanda Pharmaceuticals Today - Breaking & Trending Today

BLOOMBERG Whatd You Miss July 13, 2024 - Vimarsana News

BLOOMBERG Whatd You Miss July 13, 2024

Since the 80s on a week to week basis. If you want to take delivery for crude oil, you can put it in storage but you probably will not have use for it. If you reopen the economy, you , but thisl recoveries is very much what is expected in markets across the board. Romaine we just want to check on the markets. We did get the closing bell. Up on the three major indices. Stephen mentioned small caps a little bit earlier. The russell 2000 up about 1. 2 . Thebiggest laggards were big cap tech names. We are awaiting alphabet, also names like starbucks, ford after the bell. Scarlet in the big cap spa...

CNBC Closing Bell July 13, 2024 - Vimarsana News

CNBC Closing Bell July 13, 2024

Lots of guests coming up mel Mellody Hobson will join us. Well ask if todays the start of a downturn or a buying opportunity. The ceo of icelandbased Decode Genetics will join us. What the company has learned about how the virus spreads. Its an interesting study. Lets focus in on the big stories we are watching in this final hour of trade. Bob pisani tracking todays selloff Courtney Reagan with plunging retail Sales Numbers and wilford. Bob, a little recovery weve seen lets take a look at the s p and call this one cuomo versus the horrible Economic Data because the markets once again, cuomo mo...

Psychiatry Month in Review: April 2024 - Vimarsana News

Psychiatry Month in Review: April 2024

This month in review features top psychiatry news in the pipeline, FDA approvals, and a piece for autism awareness month.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April - Vimarsana News

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a decline of 16.9% from the March 31st total of 2,490,000 shares. Based on an average trading volume of 2,290,000 shares, the days-to-cover ratio is presently 0.9 […]

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April - Vimarsana News

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]